Medications starting with

These drops are used to lower elevated intraocular pressure and for the treatment of glaucoma.

Dosage form: drops, ophthalmic solution

ATC code: S01EC03

Manufacturer: Bruschettini S.r.I.

The medicine is used to inhibit lactation (milk production) after childbirth or to terminate it. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., amenorrhea, anovulation, galactorrhea) and for the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to inhibit lactation (milk production) after childbirth or to terminate it. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to suppress lactation (milk production) after childbirth or to terminate it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation (milk production) after childbirth or to interrupt it. It is also used in the treatment of disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma and other conditions associated with high prolactin levels.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to inhibit lactation after childbirth or to stop milk secretion. It is also indicated for the treatment of disorders related to excessive prolactin secretion (e.g., amenorrhea, lack of ovulation, galactorrhea) and for the treatment of pituitary adenoma or empty sella syndrome associated with excess prolactin.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer, S.L.

The medicine is used to inhibit lactation (milk production) after childbirth or to discontinue it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to suppress lactation (milk production) after childbirth or to interrupt it. It is also used to treat disorders related to excessive prolactin secretion (e.g., amenorrhea, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma or empty sella syndrome associated with high prolactin levels.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation (milk production) after childbirth or to interrupt it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., absence of menstruation, absence of ovulation, galactorrhea) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to suppress lactation (milk production) after childbirth or to terminate it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer BV

The medicine is used to inhibit lactation after childbirth or to stop milk secretion. It is also intended for the treatment of disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation) and for the treatment of pituitary adenoma.

Dosage form: tablets

ATC code: G02CB03

Manufacturer: Pfizer Europe MA EEIG

It is a contrast agent used during magnetic resonance imaging (MRI) scans. Its purpose is to improve the visibility and differentiation of the image, which facilitates the diagnosis of, among others, the brain, spinal cord, internal organs (liver, kidneys, heart, etc.), and blood vessels.

Dosage form: solution for injection

ATC code: V08CA02

Manufacturer: Sanochemia Pharmazeutika GmbH

It is a contrast agent used during magnetic resonance imaging (MRI) scans. It helps to improve the visibility and differentiation of the image, which facilitates the diagnosis of, among others, the brain, spinal cord, internal organs (liver, kidneys, heart, etc.), and blood vessels.

Dosage form: solution for injection

ATC code: V08CA02

Manufacturer: Sanochemia Pharmazeutika GmbH

It is a contrast agent used during magnetic resonance imaging (MRI) scans. It helps to improve the visibility and accuracy of imaging pathological changes in various organs, such as the brain, spinal cord, liver, kidneys, heart, or blood vessels.

Dosage form: solution for injection

ATC code: V08CA02

Manufacturer: Guerbet

It is a contrast agent used during magnetic resonance imaging (MRI) scans. It helps to improve the visibility of images, making it easier for doctors to detect pathological changes in the brain, spinal cord, internal organs (e.g., liver, kidneys, heart), and blood vessels.

Dosage form: solution for injection in ampoule-syringe

ATC code: V08CA02

Manufacturer: Guerbet

It is a contrast agent used during magnetic resonance imaging (MRI) scans. It is intended to improve image visibility, which helps doctors determine boundaries and detect pathological changes in various organs, such as the brain, kidneys, liver, heart, or blood vessels.

Dosage form: solution for injection

ATC code: V08CA02

Manufacturer: Guerbet

The medicine is used in adults to prevent strokes and other blood clots in the case of atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in patients with coronary artery disease or peripheral artery disease.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

It is used in the treatment of mild benign prostatic hyperplasia (BPH) in men.

Dosage form: tablets, film-coated

ATC code: G04CA55

Manufacturer: MIP Pharma GmbH

It is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: ICN Polfa Rzeszów S.A.

The medicine is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).

Dosage form: tablets

ATC code: C02CA04

Manufacturer: ICN Polfa Rzeszów S.A.

The medicine is used to treat essential hypertension and to relieve the symptoms of benign prostatic hyperplasia.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: ICN Polfa Rzeszów S.A.

Doxar is used to treat essential hypertension and to relieve symptoms associated with benign prostatic hyperplasia (BPH).

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Teva Operations Poland Sp. z o.o.

Doxar is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Teva Operations Poland Sp. z o.o.

The medicine is used for the treatment of essential hypertension and for the relief of clinical symptoms of benign prostatic hyperplasia (BPH).

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Teva Operations Poland Sp. z o.o.

The medicine is used to treat high blood pressure in women and men and to relieve symptoms associated with an enlarged prostate in men (e.g., frequent or weak urination).

Dosage form: tablets, prolonged release

ATC code: C02CA04

Manufacturer: Actavis Group PTC ehf.

It is used in the treatment of arterial hypertension and to relieve the symptoms of an enlarged prostate.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Adamed Pharma S.A. APL Swift Services (Malta) Ltd.

The medicine is used to treat arterial hypertension and to relieve symptoms caused by an enlarged prostate.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: APL Swift Services (Malta) Ltd.

The medicine is used to treat arterial hypertension and to relieve symptoms caused by an enlarged prostate.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: APL Swift Services (Malta) Ltd.

This medicine is used to treat high blood pressure and to relieve symptoms associated with an enlarged prostate in men (such as frequent or difficult urination).

Dosage form: tablets, prolonged release

ATC code: C02CA04

Manufacturer: Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH Sandoz A/S Synoptis Industrial Sp. z o.o.

It is used in the treatment of depressive states with anxiety and apprehension (including in the course of psychosis, involutional depression, or bipolar affective disorder), depression and anxiety states resulting from organic diseases, depressive-anxiety syndromes in the course of alcoholism, and neurotic disorders with symptoms of depression or anxiety.

Dosage form: capsules, hard

ATC code: N06AA12

Manufacturer: Teva Operations Poland Sp. z o.o.

The medicinal product is used in the treatment of depressive states with anxiety and apprehension (including involutional depression and bipolar affective disorder), depression and anxiety states resulting from organic diseases, depressive-anxiety syndromes in the course of alcoholism, and neurotic disorders with symptoms of depression or anxiety.

Dosage form: capsules, hard

ATC code: N06AA12

Manufacturer: Teva Operations Poland Sp. z o.o.

The medicine is used to relieve the symptoms of chronic venous insufficiency of the lower limbs (such as pain, cramps, swelling, or skin changes) and to delay the progression of mild or moderate diabetic retinopathy.

Dosage form: capsules, hard

ATC code: C05BX01

Manufacturer: Flavine Pharma France

The medicine is used to treat mild enlargement of the prostate gland that causes difficulty in urination, and in cases of high blood pressure when other medicines have not been effective.

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used to treat mild enlargement of the prostate gland that causes difficulty in urination, and to treat high blood pressure (when other medicines have not been effective).

Dosage form: tablets

ATC code: C02CA04

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used to treat various types of cancer, such as: breast cancer, stomach or intestinal cancer, lung cancer, bladder cancer, ovarian and endometrial cancer, thyroid cancer, sarcomas, lymphomas, leukemia, myeloma, as well as nerve and kidney tumors occurring in children.

Dosage form: solution for infusion, concentrate

ATC code: L01DB01

Manufacturer: Accord Healthcare Polska Sp. z o.o.

The medicine is used, among others, in the treatment of soft tissue and bone sarcomas, Hodgkin's lymphoma, lymphomas, various types of leukemias, cancer of the thyroid, breast, ovary, bladder, and lungs, as well as multiple myeloma, and cancer of the stomach, pancreas, prostate, testis, and liver.

Dosage form: solution for infusion, concentrate

ATC code: L01DB01

Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH

The medicine is used to treat various infections caused by bacteria and protozoa, including respiratory tract infections, urinary tract infections, sexually transmitted diseases, Lyme disease, and for the prevention of malaria.

Dosage form: capsules, hard

ATC code: J01AA02

Manufacturer: Synoptis Industrial Sp. z o.o.

The medicine is used to treat many infections caused by bacteria and protozoa, including respiratory tract infections (e.g., pneumonia, sinusitis), urinary tract infections, sexually transmitted diseases (e.g., chlamydiosis), gastrointestinal infections (e.g., cholera, traveler's diarrhea), Lyme disease, malaria, as well as eye and soft tissue infections.

Dosage form: capsules, hard

ATC code: J01AA02

Manufacturer: Polfarmex S.A.

The medicine is used to treat infections caused by bacteria and protozoa. This includes, among others, respiratory tract infections (e.g., pneumonia, sinusitis, pharyngitis), urinary tract infections, sexually transmitted diseases, gastrointestinal infections (e.g., cholera, salmonellosis), and certain skin and soft tissue infections.

Dosage form: solution for infusion

ATC code: J01AA02

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

It is an antibiotic used to treat various infections caused by bacteria and protozoa, such as respiratory tract infections, urinary tract infections, sexually transmitted diseases (e.g., syphilis, gonorrhea), Lyme disease, or eye infections. It is also used prophylactically in the case of malaria.

Dosage form: capsules, hard

ATC code: J01AA02

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

The medicine is intended for adults for the short-term, symptomatic treatment of occasional insomnia, especially when there are difficulties falling asleep, frequent nighttime awakenings, or waking up too early in the morning.

Dosage form: tablets, film-coated

ATC code: R06AA09

Manufacturer: Biofarm Sp. z o.o.

The medicinal product is intended for the short-term symptomatic treatment of occasional insomnia in adults over 18 years of age.

Dosage form: tablets, film-coated

ATC code: R06AA09

Manufacturer: Industria Quimica y Farmaceutica VIR S.A.

The medicinal product is used for the short-term, symptomatic treatment of occasional insomnia in adults.

Dosage form: tablets, film-coated

ATC code: R06AA09

Manufacturer: Laboratorios Alcala Farma, S.L.

The medicinal product is intended for the short-term, symptomatic treatment of occasional insomnia in adults.

Dosage form: powder, oral

ATC code: R06AA09

Manufacturer: Sincrofarm, S.L.

The medicinal product is used for the short-term, symptomatic treatment of occasional insomnia in adults.

Dosage form: powder, oral

ATC code: R06AA09

Manufacturer: Sincrofarm, S.L.